Cite
HARVARD Citation
Sánchez-Trujillo, L. et al. (2019). Phase II clinical trial testing the safety of a humanised monoclonal antibody anti-CD20 in patients with heart failure with reduced ejection fraction, ICFEr-RITU2: study protocol. BMJ open. 9 (3), p. . [Online].